Literature DB >> 23841186

The BCG vaccine: information and recommendations for use in Australia. National Tuberculosis Advisory Committee update October 2012.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23841186

Source DB:  PubMed          Journal:  Commun Dis Intell Q Rep        ISSN: 1447-4514


× No keyword cloud information.
  4 in total

1.  Bacillus Calmette-Guérin (BCG) vaccine adverse events in Victoria, Australia: analysis of reports to an enhanced passive surveillance system.

Authors:  Hazel J Clothier; Laine Hosking; Nigel W Crawford; Melissa Russell; Mee Lee Easton; Julie-Ann Quinn; Jim P Buttery
Journal:  Drug Saf       Date:  2015-01       Impact factor: 5.606

2.  Trends in Tuberculosis Incidence in the Australian-Born in Victoria: Opportunities and Challenges to Elimination.

Authors:  Ouli Xie; Ee Laine Tay; Justin Denholm
Journal:  Trop Med Infect Dis       Date:  2018-10-11

3.  Study protocol for the Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR), a randomised controlled trial to determine the non-specific effects of neonatal BCG vaccination in a low-mortality setting.

Authors:  Nicole L Messina; Kaya Gardiner; Susan Donath; Katie Flanagan; Anne-Louise Ponsonby; Frank Shann; Roy Robins-Browne; Bridget Freyne; Veronica Abruzzo; Clare Morison; Lianne Cox; Susie Germano; Christel Zufferey; Petra Zimmermann; Katie J Allen; Peter Vuillermin; Mike South; Dan Casalaz; Nigel Curtis
Journal:  BMJ Open       Date:  2019-12-15       Impact factor: 2.692

4.  A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities.

Authors:  Lena Faust; Yoko Schreiber; Natalie Bocking
Journal:  BMC Public Health       Date:  2019-11-11       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.